Thomson Reuters in asset sale talks with bourse operator Nasdaq OMX

US stock exchange operator Nasdaq OMX Group Inc (NASDAQ:NDAQ) said today that it had made a binding offer to take over the investor relations, public relations and multimedia solutions operations of domestic business information provider Thomson Reuters Corp (NYSE:TRI) for USD390m (EUR299.1m) in cash.

The buyer said it expects to sign a definitive deal after the completion of an information and consultation process, which both companies had started with relevant works councils, unions and employee representatives. The acquisition is also subject to customary closing conditions, including regulatory approvals.

Nasdaq OMX expects that the addition would boost its earnings per share in the first full year, excluding transaction-related costs.

The operations being acquired provide insight, analytics and communications solutions to more than 7,000 clients worldwide. Upon completion of the deal, which is expected to occur in the first half of 2013, they will continue to operate as independent companies within the buyer’s corporate solutions division.

Thomson Reuters acquires UK mobile platform firm Apsmart

Business information provider Thomson Reuters Corp (NYSE:TRI;TSE:TRI) said today it had taken over British mobile platform and product development company Apsmart for an undisclosed sum.

The buyer said that through the acquisition, it will boost its mobile solutions offering. Thomson Reuters added that the deal will enhance its mobile product creation, design and development, allowing it to provide additional expert-enriched content, news and solutions through mobile devices.

Apsmart was majority owned by DN Capital, one of its founders. The latter, together with Rahul Powar, creator of the first Shazam iPhone application, established the target firm in 2009. The company’s team is specialised in creating connected, data-driven applications for iOS and Android devices.

Earlier this week, Thomson Reuters said it had finalised the USD1.25bn (EUR995.4m) sale of its healthcare business to New York-based private equity firm Veritas Capital.

The sold business is now an independent company named Truven Health Analytics and providing healthcare information, analytic tools and benchmarks to hospitals, health systems, employers, health plans, government agencies and pharmaceutical companies.